Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

Fig. 2Fig. 2

Forest plot for meta-analysis and subgroup analysis according to EF(A), type of SGLT2i(B) and age(C), comparing the effects of SGLT2i with PBO in NT-proBNP, ≥ 20% Decrease in NT-proBNP(D) and BNP(E). SGLT2i, SGLT-2 inhibitor, PBO, placebo, Effect stands for WMD = Weighted Mean Difference, CI confidence interval, RR = risk ratio

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840